Mark W Kieran

Author PubWeight™ 1.13^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Phase I and pharmacokinetic study of the oral farnesyltransferase inhibitor lonafarnib administered twice daily to pediatric patients with advanced central nervous system tumors using a modified continuous reassessment method: a Pediatric Brain Tumor Consortium Study.	J Clin Oncol	2007	1.17